This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...

MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.

Drugs such as Ozempic, Wegovy, and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

Korean researchers have developed the world's first wireless OLED-based contact lens, designed to diagnose retinal conditions ...

Eye disorders such as cataracts and glaucoma fuel the sector’s demand. The rising prevalence of vision-related disorders is ...

For the first time in Ghana’s history, the country officially joins the global eye care community in commemorating World Ophthalmologist Day—a day set aside to recognise and celebrate the vital role o ...

A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.